World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
38383
World Ranking
11150
National Ranking
5733

Overview

Seth P. Lerner is affiliated with Baylor College of Medicine in the United States. Their research primarily falls within the field of Medicine, with significant contributions in Surgery, Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, and Urology.

The main topics covered in their work include Bladder and Urothelial Cancer Treatments, Urinary and Genital Oncology Studies, Urological Disorders and Treatments, Epigenetics and DNA Methylation, Esophageal Cancer Research and Treatment, Renal Cell Carcinoma Treatment, and Prostate Cancer Treatment and Research.

Frequent publication venues for their work are the Journal of Clinical Oncology, European Urology, Urologic Oncology Seminars and Original Investigations, The Journal of Urology, and European Urology Oncology.

Seth P. Lerner has collaborated extensively with several coauthors, including Ian M. Thompson, Ashish M. Kamat, Catherine M. Tangen, Melissa Plets, and Siamak Daneshmand.

Notable recent papers include:

  • Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial (2020, The Lancet Oncology)
  • Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors (2023, European Urology)
  • Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial (2020, The Lancet Oncology)
  • A Randomized Phase II Study of Coexpression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Bladder Cancer (SWOG S1314; NCT02177695) (2021, Clinical Cancer Research)
  • Phase 2 Trial of Atezolizumab in Bacillus Calmette-Guérin-unresponsive High-risk Non-muscle-invasive Bladder Cancer: SWOG S1605 (2023, European Urology)

Best Publications

  • Comprehensive molecular characterization of urothelial bladder carcinoma

    John N Weinstein;Rehan Akbani;Bradley McIntosh Broom;Wenyi Wang

  • Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

    A. Gordon Robertson;Jaegil Kim;Hikmat Al-Ahmadie;Joaquim Bellmunt

  • A Consensus Molecular Classification of Muscle-invasive Bladder Cancer.

    Aurélie Kamoun;Aurélien de Reyniès;Yves Allory;Yves Allory;Gottfrid Sjödahl

  • Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline.

    Sam S. Chang;Bernard H. Bochner;Roger Chou;Robert Dreicer

  • Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.

    Shahrokh F. Shariat;Pierre I. Karakiewicz;Ganesh S. Palapattu;Yair Lotan

  • Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy

    Roland Seiler;Roland Seiler;Hussam Al Deen Ashab;Nicholas Erho;Bas W G van Rhijn

  • Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer.

    Bernard H. Bochner;Guido Dalbagni;Michael W. Kattan;Paul Fearn

  • Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance

    Antonina V. Kurtova;Jing Xiao;Qianxing Mo;Senthil Pazhanisamy

  • Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System).

    Valeria Panebianco;Yoshifumi Narumi;Ersan Altun;Bernard H. Bochner

  • ICUD-EAU international consultation on bladder cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder

    Georgios Gakis;Jason Efstathiou;Seth P. Lerner;Michael S. Cookson

  • Methods to Improve Efficacy of Intravesical Mitomycin C: Results of a Randomized Phase III Trial

    Jessie L.-S. Au;Robert A. Badalament;M. Guillaume Wientjes;Donn C. Young

  • A Comparison of Hexaminolevulinate Fluorescence Cystoscopy and White Light Cystoscopy for the Detection of Carcinoma In Situ in Patients With Bladder Cancer: A Phase III, Multicenter Study

    Yves Fradet;H. Barton Grossman;Leonard Gomella;Seth Lerner

  • p53, p21, pRB, and p16 Expression Predict Clinical Outcome in Cystectomy With Bladder Cancer

    Shahrokh F. Shariat;Hideo Tokunaga;Jain Hua Zhou;Ja Hong Kim

  • Discrepancy between Clinical and Pathologic Stage: Impact on Prognosis after Radical Cystectomy

    Shahrokh F. Shariat;Ganesh S. Palapattu;Pierre I. Karakiewicz;Craig G. Rogers

  • Standardization of Radical Cystectomy and Pelvic Lymph Node Dissection for Bladder Cancer: A Collaborative Group Report

    Harry Herr;Cheryl Lee;Sam Chang;Seth Lerner

  • Urinary diversion after radical cystectomy for bladder cancer: Options, patient selection, and outcomes

    Richard K. Lee;Hassan Abol-Enein;Walter Artibani;Bernard Bochner

  • Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)

    Francesco Soria;Francesco Soria;Shahrokh F. Shariat;Seth P. Lerner;Hans Martin Fritsche

  • The Rationale for EN Bloc Pelvic Lymph Node Dissection for Bladder Cancer Patients with Nodal Metastases: Long-Term Results

    Seth P. Lerner;Donald G. Skinner;Gary Lieskovsky;Stuart D. Boyd

  • Three differentiation states risk-stratify bladder cancer into distinct subtypes.

    Jens Peter Volkmer;Jens Peter Volkmer;Debashis Sahoo;Robert K. Chin;Philip Levy Ho

  • The Cancer Genome Atlas Pan-Cancer analysis project

    Kyle Chang;Chad J Creighton;Caleb Davis;Lawrence Donehower

Frequent Co-Authors

Yair Lotan
Yair Lotan The University of Texas Southwestern Medical Center
Shahrokh F. Shariat
Shahrokh F. Shariat Medical University of Vienna
Pierre I. Karakiewicz
Pierre I. Karakiewicz University of Montreal
Colin P. Dinney
Colin P. Dinney The University of Texas MD Anderson Cancer Center
Ashish M. Kamat
Ashish M. Kamat The University of Texas MD Anderson Cancer Center
Wassim Kassouf
Wassim Kassouf McGill University
Yves Fradet
Yves Fradet Université Laval
Catherine M. Tangen
Catherine M. Tangen Fred Hutchinson Cancer Research Center
H. Barton Grossman
H. Barton Grossman The University of Texas MD Anderson Cancer Center
Giacomo Novara
Giacomo Novara University of Padua

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine opens the door to many related healthcare fields and advanced online degrees. For those interested in management roles within healthcare settings, exploring a masters in healthcare administration cost can help you plan financially for a leadership-focused graduate program.

If you are looking to specialize and move quickly into advanced practice, a 1 year dnp program online may be ideal, offering flexibility and speed for working nurses aiming for top clinical positions.

For those interested in pharmacy, distance learning options such as an online pharmd allow students to pursue advanced pharmaceutical education without relocating.

Finally, the demand for technology expertise is rapidly increasing in healthcare. Earning a degree in health informatics can lead to rewarding careers working with data, electronic health records, and healthcare IT systems.

Each of these pathways offers rewarding opportunities to advance your healthcare career with the convenience and flexibility of online learning.

Best Scientists Citing Seth P. Lerner

Trending Scientists

Recently Published Articles